Literature DB >> 22933662

Ventricular resynchronization therapy by direct His-bundle pacing using an internal cardioverter defibrillator.

Rafael Barba-Pichardo1, Ana Manovel Sánchez, Juan M Fernández-Gómez, Pablo Moriña-Vázquez, José Venegas-Gamero, Manuel Herrera-Carranza.   

Abstract

AIMS: Cardiac resynchronization therapy (CRT) has been demonstrated to improve the functional class of patients with refractory heart failure if QRS width is >120 ms. Addition of an internal cardioverter defibrillator diminishes the prevalence of mortality of such patients. The technique for CRT requires selective stimulation of the left ventricle (LV), commonly undertaken through the coronary sinus. This procedure is not always feasible. Direct His-bundle pacing (DHBP) might be an alternative for CRT. METHODS AND
RESULTS: Patients were selected from a population with refractory heart failure derived for CRT and internal cardioverter defibrillator insertion. Of those, patients in whom LV stimulation via the coronary sinus was not achievable and DHBP obtained left bundle branch block disappearance were included. Direct His-bundle pacing corrected basal conduction disturbances in 13 of the 16 patients (81%) selected. In four patients in whom DHBP was attempted, the electrode was not successfully fixed. In the nine remaining patients, a definitive resynchronization by DHBP was achieved, with consequent improvement in functional class and parameters of LV function as assessed by echocardiography.
CONCLUSION: Direct His-bundle pacing might be an alternative treatment for CRT in selected cases.

Entities:  

Mesh:

Year:  2012        PMID: 22933662     DOI: 10.1093/europace/eus228

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  36 in total

Review 1.  "Beauty is a light in the heart": the transformative potential of optogenetics for clinical applications in cardiovascular medicine.

Authors:  Patrick M Boyle; Thomas V Karathanos; Natalia A Trayanova
Journal:  Trends Cardiovasc Med       Date:  2014-10-16       Impact factor: 6.677

2.  Honing in on optimal ventricular pacing sites: an argument for his bundle pacing.

Authors:  Mark Young Lee; Srinath Chilakamarri Yeshwant; Daniel Lawrence Lustgarten
Journal:  Curr Treat Options Cardiovasc Med       Date:  2015-04

Review 3.  Permanent His bundle pacing: shaping the future of physiological ventricular pacing.

Authors:  Parikshit S Sharma; Pugazhendhi Vijayaraman; Kenneth A Ellenbogen
Journal:  Nat Rev Cardiol       Date:  2019-06-27       Impact factor: 32.419

Review 4.  His-Bundle Pacing and LV Endocardial Pacing as Alternatives to Traditional Cardiac Resynchronization Therapy.

Authors:  Pugazhendhi Vijayaraman; Faiz A Subzposh
Journal:  Curr Cardiol Rep       Date:  2018-09-26       Impact factor: 2.931

Review 5.  His bundle pacing.

Authors:  Jason Payne; Ann C Garlitski; Jonathan Weinstock; Munther Homoud; Christopher Madias; N A Mark Estes
Journal:  J Interv Card Electrophysiol       Date:  2018-08-13       Impact factor: 1.900

Review 6.  Should His Bundle Pacing Be Preferred over Cardiac Resynchronization Therapy Following Atrioventricular Junction Ablation?

Authors:  Zak Loring; Albert Y Sun
Journal:  Cardiol Clin       Date:  2019-02-10       Impact factor: 2.213

Review 7.  His Bundle Pacing: Techniques and Outcomes.

Authors:  Mads Brix Kronborg; Jens Cosedis Nielsen
Journal:  Curr Cardiol Rep       Date:  2016-07       Impact factor: 2.931

Review 8.  Permanent His Bundle Pacing for Cardiac Resynchronization.

Authors:  William A Huang; Maereg A Wassie; Olujimi A Ajijola
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-03-06

9.  Ablate and his bundle pace.

Authors:  Ron Sela; Eli Kalfon; Shaul Atar
Journal:  J Cardiol Cases       Date:  2017-11-21

10.  Usefulness of His Bundle Pacing to Achieve Electrical Resynchronization in Patients With Complete Left Bundle Branch Block and the Relation Between Native QRS Axis, Duration, and Normalization.

Authors:  Alexandra E Teng; Daniel L Lustgarten; Pugazhendhi Vijayaraman; Roderick Tung; Kalyanam Shivkumar; Galen S Wagner; Olujimi A Ajijola
Journal:  Am J Cardiol       Date:  2016-05-28       Impact factor: 2.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.